ArticleQuantitative imaging in medicine and surgery2022
Differentiation of predominantly osteolytic from osteoblastic spinal metastases based on standard magnetic resonance imaging sequences: a comparison of radiomics model versus semantic features logistic regression model findings.
Article in Quantitative imaging in medicine and surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Prognostic analysis of percutaneous vertebroplasty (PVP) combined withWorld journal of surgical oncology · 2023Trial
- Applications and Performance of Artificial Intelligence in Spinal Metastasis Imaging: A Systematic Review.Journal of clinical medicine · 2025Review
- MRI Radiomics Analysis in the Diagnostic Differentiation of Malignant Soft Tissue Myxoid Sarcomas From Benign Soft Tissue Musculoskeletal Myxomas.Journal of magnetic resonance imaging : JMRI · 2025Article
- MRI-based radiomics for noninvasive prediction of T790M resistance mutation in lung cancer spinal metastases: an exploratory study.Frontiers in cell and developmental biology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The aim of this study was to compare the ability of a standard magnetic resonance imaging (MRI)-based radiomics model and a semantic features logistic regression model in differentiating between predominantly osteolytic and osteoblastic spinal metastases. Methods: We retrospectively analyzed standard MRIs and computed tomography (CT) images of 78 lesions of spinal metastases, of which 52 and 26 were predominantly osteolytic and osteoblastic, respectively. CT images were used as references for determining the sensitivity and specificity of standard MRI. Five standard MRI semantic features of each lesion were evaluated and used for constructing a logistic regression model to differentiate between predominantly osteolytic and osteoblastic metastases. For each lesion, 107 radiomics features were extracted. Six features were selected using a support vector machine (SVM) and were used for constructing classification models. Model performance was measured by means of the area under the curve (AUC) approach and compared using receiver operating characteristics (ROC) curve analysis. Results: The signal intensity on T1-weighted (T1W), T2-weighted (T2W), and fat-suppressed T2-weighted (FS-T2W) MRI sequences were significantly different between predominantly osteolytic and osteoblastic spinal metastases (P<0.001), as is the case with the existence of soft-tissue masses. The overall prediction accuracy of the models based on radiomics and semantic features was 78.2% and 75.6%, respectively, with corresponding AUCs of 0.82 and 0.79, respectively. Conclusions: The standard MRI-based radiomics model outperformed the semantic features logistic regression model with regard to differentiating predominantly osteolytic and osteoblastic spinal metastases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.